Angie is an experienced strategic global business leader who has 25+ years of experience in the Life Sciences, Pharma/Biotech and CRO industries with broad market knowledge and significant strategy, corporate development, marketing, market research/competitive intelligence, sales/business development, products, services and portfolio management, mergers & acquisitions, strategic partnerships, licensing, operations, and consulting experience.
Angie leverages both a science and business background to help global companies develop and commercialize their products & services, achieve their business goals and objectives, and consistently deliver successful results in complex high-tech markets. She has held leadership positions at a variety of industry leading companies in life sciences, genomics, drug discovery, and preclinical drug development such as: Science and Medicine Group, Eurofins Pharma Discovery Services, Promega, Covance Discovery/Early Development/PreClinical, Merck KGaA/EMD Biosciences, Invitrogen Drug Discovery Solutions, Sigma, Whitehead Institute/MIT Center for Genome Research, and Amersham Life Sciences. Angie has also previously founded her own consulting company, BioToBiz, to help companies capitalize on bringing scientific business opportunities to their full commercial potential.
Expertise
- Strategic Planning, Marketing, Business Development, and Sales Leadership
- Product/Services Management, New Product & Services Stage-Gate Development, Go-To-Market Strategies & Tactics, and Product Life Cycle Roadmaps
- Corporate Development, M&A, Strategic Partnerships, Licensing, and Technology Assessment
- Market Analysis, Competitive/Business Analysis, and Market Research Studies
- Development and leadership of global matrix/cross-organizational teams
Angie is an experienced strategic global business leader who has 25+ years of experience in the Life Sciences, Pharma/Biotech and CRO industries with broad market knowledge and significant strategy, corporate development, marketing, market research/competitive intelligence, sales/business development, products, services and portfolio management, mergers & acquisitions, strategic partnerships, licensing, operations, and consulting experience.
Angie leverages both a science and business background to help global companies develop and commercialize their products & services, achieve their business goals and objectives, and consistently deliver successful results in complex high-tech markets. She has held leadership positions at a variety of industry leading companies in life sciences, genomics, drug discovery, and preclinical drug development such as: Science and Medicine Group, Eurofins Pharma Discovery Services, Promega, Covance Discovery/Early Development/PreClinical, Merck KGaA/EMD Biosciences, Invitrogen Drug Discovery Solutions, Sigma, Whitehead Institute/MIT Center for Genome Research, and Amersham Life Sciences. Angie has also previously founded her own consulting company, BioToBiz, to help companies capitalize on bringing scientific business opportunities to their full commercial potential.
Expertise
- Strategic Planning, Marketing, Business Development, and Sales Leadership
- Product/Services Management, New Product & Services Stage-Gate Development, Go-To-Market Strategies & Tactics, and Product Life Cycle Roadmaps
- Corporate Development, M&A, Strategic Partnerships, Licensing, and Technology Assessment
- Market Analysis, Competitive/Business Analysis, and Market Research Studies
- Development and leadership of global matrix/cross-organizational teams